The association of MRP expression with PRIMA‐1 resistance, MRP1’s role in redox regulation and export of GSH‐conjugated drugs, and the fact that MQ conjugates to GSH led us to hypothesize that inhibition of MRP1 in mutant TP53‐carrying tumor cells enhances sensitivity to APR‐246. The gene discussed is ABCC1; the disease is neoplasm.